A case of urgent colonoscopic hemostasis of a cecal hemorrhagic ulceration in a patient receiving heparin for COVID‐19 coagulopathy. Issue 1 (23rd October 2020)

• Record Type: Journal Article
• Authors: Yoshida, Naohisa; Hirose, Ryohei; Watanabe, Makoto; Yamazaki, Masaski; Hashimoto, Satoru; Matsubara, Shin; Kasamatsu, Yu; Fujita, Naohisa; Rani, Rafiz Abdul; Dohi, Osamu; Inoue, Ken; Naito, Yuji; Itoh, Yoshito
• Is Part Of: JGH open. Volume 5:Issue 1(2021)
• Page Start: 160
• Page End: 162
• Publication Date: 2020-10-23
• Subjects: colonoscopy -- COVID‐19 -- cytomegalovirus -- hemorrhage -- personal protective equipment
• DOI: 10.1002/jgh3.12435
• Languages: English
• ISSNs: 2397-9070

Abstract

Abstract: COVID‐19 rarely causes lower gastrointestinal bleeding even though its RNA has been detected in patient's stool. Urgent colonoscopy in a COVID‐19 patient with massive bloody stool requires various procedural and equipment considerations. Here, we present a case of colonoscopic hemostasis of a cecal hemorrhagic ulceration in a patient on heparin for COVID‐19 coagulopathy. We also share various management methods for the prevention of COVID‐19 contamination. A 71‐year‐old man was diagnosed with COVID‐19 pneumonia and subsequently underwent hemodiafiltration. Heparin was initiated for COVID‐19 coagulopathy. At day 42, the patient experienced 2000 mL of bloody stool. An operator performed urgent colonoscopy with three assistants in a negative‐pressure room with full personal protective equipment. A hemorrhagic ulceration was detected at the cecum, and endoscopic hemostasis was performed. Immunohistochemistry was positive for cytomegalovirus. Postprocedure, the endoscopic systems were thoroughly cleaned, and specific measures for endoscope reprocessing and disinfection were performed to prevent contamination with COVID‐19. Abstract : Urgent colonoscopy for a patient with COVID‐19 having massive bloody stool needs various considerations for equipment and procedures. Here, we present the first case report of colonoscopic hemostasis ofcecal hemorrhagic ulceration for a patient receiving heparin for COVID‐19 coagulopathy and also showed various management methods toprevent contamination of COVID‐19.